*[email protected] 1 Department of Infectious Disease, Imperial College London, Du Cane Rd, London W12 0NN UK. 2 Department of Biotechnology, Hezekiah University Umudi, Imo State, Nigeria. Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson’s Disease: From Pathological Mechanisms to Therapeutic Opportunities

preprint OA: closed
Full text JSON View at publisher

Abstract

In Parkinson’s disease (PD), blood-brain barrier (BBB) dysfunction is shifting from being viewed as a passive marker of damage to a key pathological driver and potential therapeutic target. Its disruption involves mechanisms such as abnormal α-synuclein transport, tight junction breakdown, inflammatory activation, and vascular remodeling, all of which significantly disturb the neural microenvironment. Imaging technologies are playing an increasingly pivotal role in unraveling these complex processes. Based on current clinical and experimental evidence, this review outlines the major mechanisms of BBB disruption in PD and focuses on recent advances in multiscale imaging techniques for BBB research. It covers super-resolution microscopy, two-photon imaging, MRI, and PET, emphasizing their critical value in mechanistic investigation, functional assessment, and target localization. Multimodal imaging enables cross-scale integration—from nanoscopic to macroscopic levels, and from laboratory research to clinical application—and holds promise for building a “mechanism–imaging–intervention” framework that may accelerate the translation from pathophysiological understanding to clinical intervention.
Full text 9,833 characters · extracted from preprint-html · click to expand
*[email protected] 1 Department of Infectious Disease, Imperial College London, Du Cane Rd, London W12 0NN UK. 2 Department of Biotechnology, Hezekiah University Umudi, Imo State, Nigeria. Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson’s Disease: From Pathological Mechanisms to Therapeutic Opportunities | Authorea try { document.documentElement.classList.add('js'); } catch (e) { } var _gaq = _gaq || []; _gaq.push(['_setAccount', 'G-8VDV14Y67G']); _gaq.push(['_trackPageview']); (function() { var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true; ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s); })(); Skip to main content Preprints Collections Wiley Open Research IET Open Research Ecological Society of Japan All Collections About About Authorea FAQs Contact Us Quick Search anywhere Search for preprint articles, keywords, etc. Search Search ADVANCED SEARCH SCROLL European Journal of Neuroscience This is a preprint and has not been peer reviewed. Data may be preliminary. 19 July 2025 V1 Latest version Share on * [email protected] 1 Department of Infectious Disease, Imperial College London, Du Cane Rd, London W12 0NN UK. 2 Department of Biotechnology, Hezekiah University Umudi, Imo State, Nigeria. Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson’s Disease: From Pathological Mechanisms to Therapeutic Opportunities Authors : Zihao Lu , Haolin Yin , Pan Xiang , Xuan Yi , Xiaohe Tian , and Qiyong Gong 0000-0002-5912-4871 [email protected] Authors Info & Affiliations https://doi.org/10.22541/au.175289960.04881326/v1 315 views 202 downloads Contents Abstract Supplementary Material Information & Authors Metrics & Citations View Options References Figures Tables Media Share Abstract In Parkinson’s disease (PD), blood-brain barrier (BBB) dysfunction is shifting from being viewed as a passive marker of damage to a key pathological driver and potential therapeutic target. Its disruption involves mechanisms such as abnormal α-synuclein transport, tight junction breakdown, inflammatory activation, and vascular remodeling, all of which significantly disturb the neural microenvironment. Imaging technologies are playing an increasingly pivotal role in unraveling these complex processes. Based on current clinical and experimental evidence, this review outlines the major mechanisms of BBB disruption in PD and focuses on recent advances in multiscale imaging techniques for BBB research. It covers super-resolution microscopy, two-photon imaging, MRI, and PET, emphasizing their critical value in mechanistic investigation, functional assessment, and target localization. Multimodal imaging enables cross-scale integration—from nanoscopic to macroscopic levels, and from laboratory research to clinical application—and holds promise for building a “mechanism–imaging–intervention” framework that may accelerate the translation from pathophysiological understanding to clinical intervention. * [email protected] 1 Department of Infectious Disease, Imperial College London, Du Cane Rd, London W12 0NN UK. 2 Department of Biotechnology, Hezekiah University Umudi, Imo State, Nigeria. Title page * [email protected] 1 Department of Infectious Disease, Imperial College London, Du Cane Rd, London W12 0NN UK. 2 Department of Biotechnology, Hezekiah University Umudi, Imo State, Nigeria. Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson’s Disease: From Pathological Mechanisms to Therapeutic Opportunities Zihao Lu a1 , Haolin Yin a1 , Pan Xiang 1 , Xuan Yi 4 , Xiaohe Tian 1,2 *, Qiyong Gong 1,2,3 * Running Head: Word count :10593 Figure count :5 Affiliations: 1 Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, West China Hospital of Sichuan University, Sichuan University, Chengdu, Sichuan, China 2 The Xiamen Key Laboratory of Psychoradiology and Neuromodulation, West China Xiamen Hospital of Sichuan University, Xiamen, Fujian, China 3 Department of Radiology, West China Xiamen Hospital of Sichuan University, Xiamen, Fujian, China 4 Department of Machine Design & Manufacturing and Automation, School of Mechanical Engineering, Sichuan University, Chengdu, China * Correspondence author: Xiaohe Tian , Ph.D., Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, 610000, Chengdu, Sichuan, China. Email: [email protected] Qiyong Gong , M.D., Ph.D., Department of Radiology, West China Xiamen Hospital of Sichuan University, 699 Jinyuan Xi Road, Jimei District, 361021 Xiamen, Fujian, China. Email: [email protected] a ZHL and HLY contributed equally to this work. Acknowledgements This study was supported by National Key R&D Program of China (2022YFC2009900) and the National Natural Science Foundation of China (Grant Nos. 81621003, 81761128023, 81820108018 and 82027808) and NIH/NIMH R01MH112189-01. Declaration of competing interest All the authors declare that they have no competing interests in this paper. Supplementary Material File (manuscript-marked-version.docx) Download 342.26 KB File (manuscript-unmarked-version.docx) Download 340.79 KB File (table-1.docx) Download 36.74 KB File (table-2.docx) Download 22.34 KB Information & Authors Information Version history V1 Version 1 19 July 2025 Copyright This work is licensed under a Non Exclusive No Reuse License. Collection European Journal of Neuroscience Keywords alpha-synuclein blood brain barrier mri parkinson's disease Authors Affiliations Zihao Lu Sichuan University West China Hospital Department of Radiology View all articles by this author Haolin Yin Sichuan University West China Hospital Department of Radiology View all articles by this author Pan Xiang Sichuan University West China Hospital Department of Radiology View all articles by this author Xuan Yi Sichuan University School of Mechanical Engineering View all articles by this author Xiaohe Tian Sichuan University West China Hospital Department of Radiology View all articles by this author Qiyong Gong 0000-0002-5912-4871 [email protected] Sichuan University West China Hospital Department of Radiology View all articles by this author Metrics & Citations Metrics Article Usage 315 views 202 downloads .FvxKWukQNSOunydq8rnd { width: 100px; } Citations Download citation Zihao Lu, Haolin Yin, Pan Xiang, et al. * [email protected] 1 Department of Infectious Disease, Imperial College London, Du Cane Rd, London W12 0NN UK. 2 Department of Biotechnology, Hezekiah University Umudi, Imo State, Nigeria. Multimodal Imaging of Blood–Brain Barrier Dysfunction in Parkinson’s Disease: From Pathological Mechanisms to Therapeutic Opportunities. Authorea . 19 July 2025. DOI: https://doi.org/10.22541/au.175289960.04881326/v1 If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download. For more information or tips please see 'Downloading to a citation manager' in the Help menu . Format Please select one from the list RIS (ProCite, Reference Manager) EndNote BibTex Medlars RefWorks Direct import Tips for downloading citations document.getElementById('citMgrHelpLink').addEventListener('click', function() { popupHelp(this.href); return false; }); $(".js__slcInclude").on("change", function(e){ if ($(this).val() == 'refworks') $('#direct').prop("checked", false); $('#direct').prop("disabled", ($(this).val() == 'refworks')); }); View Options View options PDF View PDF Figures Tables Media Share Share Share article link Copy Link Copied! Copying failed. Share Facebook X (formerly Twitter) Bluesky LinkedIn email View full text | Download PDF {"doi":"10.22541/au.175289960.04881326/v1","type":"Article"} Now Reading: Share Figures Tables Close figure viewer Back to article Figure title goes here Change zoom level Go to figure location within the article Download figure Toggle share panel Toggle share panel Share Toggle information panel Toggle information panel Go to previous graphic Go to next graphic Go to previous table Go to next table All figures All tables View all material View all material xrefBack.goTo xrefBack.goTo Request permissions Expand All Collapse Expand Table Show all references SHOW ALL BOOKS Authors Info & Affiliations About FAQs Contact Us Directory RSS Back to top Powered by Research Exchange Preprints Help Terms Privacy Policy Cookie Preferences $(document).ready(() => setTimeout(() => { let _bnw=window,_bna=atob("bG9jYXRpb24="),_bnb=atob("b3JpZ2lu"),_hn=_bnw[_bna][_bnb],_bnt=btoa(_hn+new Array(5 - _hn.length % 4).join(" ")); $.get("/resource/lodash?t="+_bnt); },4000)); (function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'a00b54c48ec94193',t:'MTc3OTYxNTU0NQ=='};var a=document.createElement('script');a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-07-12T06:46:07.823367+00:00